DiaMedica Therapeutics Inc.

Historical 13F Holders

Symbol
DMAC
CUSIP
25253X207
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 25253X207 since 12/18/2024, largest first.

Filer % of Class Filed
Trill AB 13G/A
16.9% 2/6/2026
Event 12/31/2025
TomEnterprise AB 13G/A
16.3% 7/30/2025
Event 7/23/2025
Richard Jacinto II 13G/A 9.6% 11/7/2025
Event 9/30/2025
Cooperman Leon G. 13G/A 6.6% 2/17/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Dialectic Capital Management, LP 13G/A
0.3% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 39 1.87 M $15.4M
2026 Q2 89 12.5 M $88.3M
2026 Q1 100 11.8 M $80.0M
2025 Q4 92 12.1 M $96.0M
2025 Q3 78 12.8 M $82.8M
2025 Q2 59 8.76 M $34.2M
2025 Q1 59 7.51 M $28.5M
2024 Q4 46 6.74 M $36.6M
2024 Q3 41 5.58 M $23.3M
2024 Q2 33 5.06 M $14.9M
2024 Q1 33 4.60 M $12.7M
2023 Q4 39 3.84 M $10.9M
2023 Q3 38 4.25 M $11.0M
2023 Q2 33 3.49 M $15.1M
2023 Q1 26 2.57 M $3.93M
2022 Q4 29 2.52 M $3.99M
2022 Q3 27 2.53 M $3.14M
2022 Q2 31 3.67 M $7.42M
2022 Q1 36 4.01 M $10.0M
2021 Q4 40 4.00 M $14.9M
2021 Q3 36 2.81 M $11.2M
2021 Q2 44 3.79 M $16.9M
2021 Q1 42 5.69 M $88.1M
2020 Q4 37 5.98 M $60.6M
2020 Q3 34 6.71 M $28.4M
2020 Q2 24 3.03 M $21.0M
2020 Q1 23 2.93 M $8.24M
2019 Q4 16 807 k $3.91M
2019 Q3 18 957 k $1.98M
2019 Q2 17 1.28 M $6.37M
2019 Q1 12 1.01 M $4.60M
2018 Q4 10 1.03 M $3.00M